医药行业周报:新一批医药标的3月“圆梦进通”

国联民生证券
Mar 08

医药行情回顾&分析&近期判断1)行情回顾:当周(03.02-03.06)医药生物指数环比-2.78%,跑输创业板指数和沪深300 指数。在所有行业中,当周(03.02-03.06)医药涨跌幅排在第15 位。2026 年初至今,医药涨跌幅排在第22 位。医药指数前半周继续大幅调整,周五反弹。结构上看,部分维生素涨价逻辑表现不错,创新药引领周五大反攻。医药成交总额4451.42 亿元,沪深总成交额为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10